Search

Displaying results 9951 - 9960 of 10000 in total
  1. Drug

    Uplarafenib

    go.drugbank.com/drugs/DB21661
    Experimental

    Uplarafenib is a small molecule drug. The usage of the INN stem '-rafenib' in the name indicates that Uplarafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor. … Uplarafenib has a monoisotopic molecular weight of 494.12 Da.

  2. Drug

    Relicpixant

    go.drugbank.com/drugs/DB21671
    Experimental

    Relicpixant is a small molecule drug. The usage of the INN stem '-pixant' in the name indicates that Relicpixant is a purinoreceptor (P2X) antagonist. … Relicpixant has a monoisotopic molecular weight of 500.07 Da.

  3. Drug

    Oveporexton

    go.drugbank.com/drugs/DB21680
    Approved

    Oveporexton is an orally administered orexin receptor 2 (OX2R) agonist used to treat narcolepsy type 1 (NT1). … [L64069] Oveporexton has been recommended for scheduling as a controlled substance, and its final controlled-substance schedule and commercial availability are pending a determination by the Drug Enforcement

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
  4. Drug

    Muvadenant

    go.drugbank.com/drugs/DB21684
    Experimental

    Muvadenant is a small molecule drug. The usage of the INN stem '-adenant' in the name indicates that Muvadenant is a adenosin receptor antagonist. … Muvadenant has a monoisotopic molecular weight of 430.17 Da.

  5. Drug

    Darbinurad

    go.drugbank.com/drugs/DB21695
    Experimental

    Darbinurad is a small molecule drug. The usage of the INN stem '-inurad' in the name indicates that Darbinurad is a urate transporter inhibitor. … Darbinurad has a monoisotopic molecular weight of 324.09 Da.

  6. Drug

    Surzetoclax

    go.drugbank.com/drugs/DB21698
    Investigational

    Surzetoclax is a small molecule drug. The usage of the INN stem '-toclax' in the name indicates that Surzetoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor. … Surzetoclax has a monoisotopic molecular weight of 1038.41 Da.

  7. Drug

    Remlifanserin

    go.drugbank.com/drugs/DB21707
    Experimental

    Remlifanserin is a small molecule drug. The usage of the INN stem '-anserin' in the name indicates that Remlifanserin is a serotonin receptor antagonist. … Remlifanserin has a monoisotopic molecular weight of 429.22 Da.

  8. Drug

    Envudeucitinib

    go.drugbank.com/drugs/DB21716
    Investigational

    Envudeucitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Envudeucitinib is a Janus kinase inhibitor. … Envudeucitinib has a monoisotopic molecular weight of 426.23 Da.

  9. Drug

    Bimokalner

    go.drugbank.com/drugs/DB21717
    Investigational

    Bimokalner is a small molecule drug. The usage of the INN stem '-kalner' in the name indicates that Bimokalner is a opener of calcium-activated (maxi-K) K+-channel. … Bimokalner has a monoisotopic molecular weight of 355.1 Da.

  10. Drug

    Zemprocitinib

    go.drugbank.com/drugs/DB21719
    Experimental

    Zemprocitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Zemprocitinib is a Janus kinase inhibitor. … Zemprocitinib has a monoisotopic molecular weight of 345.13 Da.